Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALPL | P05186 | 1/20 | 0.46 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.45 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.45 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.41 |
| ▸ | KDM2B | Q8NHM5 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27729259 | 0.98 | ALPL (0.45) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| Anthraquinone SCHEMBL28552724 | 0.92 | BRD4 (0.46) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| SCHEMBL3528957 | 0.82 | ELANE (0.60) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| SCHEMBL6972429 | 0.82 | ALPL (0.47) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| SCHEMBL2646108 | 0.81 | ALPL (0.46) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| SCHEMBL10646541 | 0.81 | SLC22A12 (0.48) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| SCHEMBL29469931 | 0.81 | PTGES2 (0.55) | ALPLSLC22A12SLC40A1PTGES2HTR6 | |
| SCHEMBL122293 | 0.81 | SLC22A12 (0.48) | ALPLSLC22A12SLC40A1PTGES2BRD4 | |
| SCHEMBL692280 | 0.81 | PTGES2 (0.55) | ALPLSLC22A12SLC40A1PTGES2HTR6 | |
| SCHEMBL6039108 | 0.81 | SLC22A12 (0.48) | ALPLSLC22A12SLC40A1PTGES2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008877-A1 | HIGH MOLECULAR WEIGHT AND HIGHLY FUNCTIONAL VINYLIDENE FLUORIDE (VDF) BASED COPOLYMERS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2026-01-08 | — | — | US | disclosed |
| EP-4536395-A1 | CLAY COMPOSITE SUPPORT-ACTIVATORS AND CATALYST COMPOSITIONS | Formosa Plastics Corporation, U.S.A. (US) | 2025-04-16 | — | — | EP | disclosed |
| EP-4496819-A1 | HIGH MOLECULAR WEIGHT AND HIGHLY FUNCTIONAL VINYLIDENE FLUORIDE (VDF) BASED COPOLYMERS | Technion Research & Development Foundation Limited (IL) | 2025-01-29 | — | — | EP | disclosed |
| CN-119278097-A | Clay complex support-activator and catalyst composition | 美国台塑公司 | 2025-01-07 | — | — | CN | disclosed |
| WO-2024221045-A1 | IMMUNOGENIC COMPOSITION | GRIFFITH UNIVERSITY (AU) | 2024-10-31 | — | — | WO | disclosed |
| WO-2023239560-A1 | CLAY COMPOSITE SUPPORT-ACTIVATORS AND CATALYST COMPOSITIONS | FORMOSA PLASTICS CORPORATON, U.S.A. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20230399420-A1 | CLAY COMPOSITE SUPPORT-ACTIVATORS AND CATALYST COMPOSITIONS | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2023-12-14 | — | — | US | disclosed |
| WO-2023181035-A1 | HIGH MOLECULAR WEIGHT AND HIGHLY FUNCTIONAL VINYLIDENE FLUORIDE (VDF) BASED COPOLYMERS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2023-09-28 | — | — | WO | disclosed |
| EP-3239190-B1 | POLYMERIZATION CATALYSTS FOR PRODUCING POLYMERS WITH LOW LEVELS OF LONG CHAIN BRANCHING | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2020-01-29 | — | — | EP | disclosed |
| US-10365262-B2 | Method of monitoring a parameter of a hydrocarbon well, pipeline or formation | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2019-07-30 | — | — | US | disclosed |
| CN-1436083-A | Preparation of pathogen inactivated low immunogenic erythrocyte solution | CERUS CORP (US) | 2003-08-13 | — | — | CN | disclosed |
| WO-2003047650-A2 | PREPARATION OF RED BLOOD CELLS HAVING REDUCED IMMUNOGENICITY | CERUS CORPORATION (US) | 2003-06-12 | — | — | WO | disclosed |
| EP-1284743-A2 | PREPARATION OF A PATHOGEN INACTIVATED SOLUTION OF RED BLOOD CELLS HAVING REDUCED IMMUNOGENICITY | Cerus Corporation (US) | 2003-02-26 | — | — | EP | disclosed |
| US-20020042043-A1 | Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity | STASSINOPOULOS ADONIS (US) | 2002-04-11 | — | — | US | disclosed |
| WO-2001091775-A2 | PREPARATION OF A PATHOGEN INACTIVATED SOLUTION OF RED BLOOD CELLS HAVING REDUCED IMMUNOGENICITY | CERUS CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
| EP-0921817-B1 | PEGYLATION PROCESS | POLYMASC PHARMACEUTICALS PLC (GB) | 2001-03-28 | — | — | EP | disclosed |
| EP-0921817-A1 | PEGYLATION PROCESS | PolyMASC Pharmaceuticals plc (GB) | 1999-06-16 | — | — | EP | disclosed |
| EP-0906293-A1 | SUBSTITUTED SULPHONYL AMINO(THIO)CARBONYL COMPOUNDS AND THEIR USE AS HERBICIDES | BAYER AG (DE) | 1999-04-07 | — | — | EP | disclosed |
| WO-1998032466-A1 | PEGYLATION PROCESS | POLYMASC PHARMACEUTICALS PLC (GB) | 1998-07-30 | — | — | WO | disclosed |
| WO-1997046540-A1 | SUBSTITUTED SULPHONYL AMINO(THIO)CARBONYL COMPOUNDS AND THEIR USE AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008877-A1 | HIGH MOLECULAR WEIGHT AND HIGHLY FUNCTIONAL VINYLIDENE FLUORIDE (VDF) BASED COPOLYMERS | MACF1, FIS1, PCNA | ALPL 2450/4885SLC22A12 3578/4885SLC40A1 2890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.